IGFBP7 intragenic mutations were also not found in relation to down-regulation in breast and colorectal cancers [54], although there is evidence of epigenetic silencing occurring in other types of cancer cell lines [24-26,41]. The gene discussed is IGFBP7; the disease is cancer.